Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
GateRouter
Smartly choose from 40+ AI models, with 0% extra fees
Insmed: Q4 Earnings Snapshot
Insmed: Q4 Earnings Snapshot
Associated Press Finance
Thu, February 19, 2026 at 9:14 PM GMT+9 1 min read
In this article:
INSM
+0.39%
BRIDGEWATER, N.J. (AP) — BRIDGEWATER, N.J. (AP) — Insmed Inc. (INSM) on Thursday reported a loss of $328.5 million in its fourth quarter.
On a per-share basis, the Bridgewater, New Jersey-based company said it had a loss of $1.54.
The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.07 per share.
The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $263.8 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $263.9 million.
For the year, the company reported a loss of $1.28 billion, or $6.42 per share. Revenue was reported as $606.4 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on INSM at
Terms and Privacy Policy
Privacy Dashboard
More Info